NCT06815328Not yet recruiting
Efficacy of Shock Wave Therapy in Post-Stroke Muscle Spasticity Management
Efficacy of Shock Wave Therapy in Patients with Muscle Spasticity After a Stroke
Source: ClinicalTrials.gov · Last updated 12 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this clinical trial is to evaluate the efficacy and safety of shock wave therapy (SWT) in reducing muscle spasticity in patients who have suffered a stroke. The main questions it aims to answer are: Does SWT reduce muscle tone and improve joint range of motion in post-stroke patients with spasticity? Does SWT improve the quality of life for these patients? What side effects, if any, occur during or after SWT? Researchers will compare SWT to conventional spasticity treatments to determine its effectiveness and potential advantages. Participants will: Undergo SWT sessions as part of their rehabilitation protocol over a period of 8 weeks. Attend follow-up visits to assess muscle tone, joint mobility, and overall functional improvement. Complete quality-of-life questionnaires to measure the therapy's impact on daily living.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 24 Jan 2025
- Start date
- 15 Mar 2025
- Primary completion date
- 30 Mar 2025
- Lead sponsor
- University of Oviedo
- Diseases
- Stroke
- NCT number
- NCT06815328
What you commit to
- Study type: Interventional
- Planned participants: 50
- From 15 Mar 2025 to the primary completion date, 30 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- "Inclusion Criteria":
- Adults aged 18 years or older.
- Confirmed diagnosis of stroke (ischemic or hemorrhagic) at least 6 months prior to enrollment.
- Clinically diagnosed muscle spasticity, measured by the Modified Ashworth Scale (MAS), with a score of 0 to 3.
- Stable medical condition that permits participation in the intervention.
- No significant changes in spasticity-related treatment for at least 3 months prior to the study.
- Ability to provide written informed consent to participate in the study.
- Ability to attend weekly sessions and follow-up visits as required.
- "Exclusion Criteria":
- Severe spasticity or contractures unresponsive to prior treatments.
- Contraindications to Shock Wave Therapy, including:
- Local infections in the treatment area.
- Known or suspected malignancy near the treatment site.
- Severe bleeding disorders or anticoagulation therapy.
- Pregnancy.
- Neurological conditions other than stroke that could interfere with study outcomes (e.g., Parkinson's disease, multiple sclerosis).
- Recent treatments that might interfere with spasticity assessment, including:
- Injections of botulinum toxin within the past 6 months.
- Recent surgery or other interventions targeting spasticity.
- Cognitive impairment or other conditions preventing the participant from following instructions or completing study tasks.
- Severe cardiovascular, renal, or hepatic disease that might complicate therapy or participation.
- Inability to commit to follow-up visits or complete the intervention protocol due to logistical, mobility, or health-related issues.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Oviedo Coordinator of this site? Confirm its status | Oviedo | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.